HK1205687A1 - Prophylactic and or therapeutic agent for radiation damage - Google Patents

Prophylactic and or therapeutic agent for radiation damage

Info

Publication number
HK1205687A1
HK1205687A1 HK15106310.3A HK15106310A HK1205687A1 HK 1205687 A1 HK1205687 A1 HK 1205687A1 HK 15106310 A HK15106310 A HK 15106310A HK 1205687 A1 HK1205687 A1 HK 1205687A1
Authority
HK
Hong Kong
Prior art keywords
prophylactic
therapeutic agent
radiation damage
radiation
damage
Prior art date
Application number
HK15106310.3A
Other languages
English (en)
Chinese (zh)
Inventor
Tohru Tanaka
Motowo Nakajima
Fuminori Abe
Hidenori Ito
Kiwamu Takahashi
Kouji Matsushima
Satoshi Ueha
Abejun
Original Assignee
Univ Tokyo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tokyo filed Critical Univ Tokyo
Publication of HK1205687A1 publication Critical patent/HK1205687A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15106310.3A 2012-07-23 2015-07-02 Prophylactic and or therapeutic agent for radiation damage HK1205687A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012163110 2012-07-23
PCT/JP2013/004292 WO2014017046A1 (ja) 2012-07-23 2013-07-11 放射線障害の予防及び／又は治療剤

Publications (1)

Publication Number Publication Date
HK1205687A1 true HK1205687A1 (en) 2015-12-24

Family

ID=49996874

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15106310.3A HK1205687A1 (en) 2012-07-23 2015-07-02 Prophylactic and or therapeutic agent for radiation damage
HK15107650.9A HK1206987A1 (en) 2012-07-23 2015-08-08 Prophylactic and or therapeutic agent for radiation damage

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15107650.9A HK1206987A1 (en) 2012-07-23 2015-08-08 Prophylactic and or therapeutic agent for radiation damage

Country Status (7)

Country Link
US (1) US9895331B2 (xx)
EP (1) EP2875812B1 (xx)
JP (1) JP5920902B2 (xx)
CN (1) CN104487066B (xx)
HK (2) HK1205687A1 (xx)
TW (1) TWI637743B (xx)
WO (1) WO2014017046A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1648952T3 (en) 2003-06-03 2018-05-28 The Us Gov As Represented By The Department Of Health And Human Services Dietary supplements and therapeutic compositions comprising (R) -3-hydroxybutyrate derivatives
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
AU2013337308B2 (en) * 2012-11-05 2018-06-21 Tdeltas Ketone bodies to protect tissues from damage by ionizing radiation
GB201304467D0 (en) 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
BR112015023334B1 (pt) 2013-03-14 2021-05-18 Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services processo para produção de (r)-3hidroxibutil (r)-3-hidroxibutirato
JP6923164B2 (ja) 2016-12-27 2021-08-18 ＭｉＺ株式会社 放射線障害防御剤
CN111060697A (zh) * 2019-02-24 2020-04-24 中国疾病预防控制中心辐射防护与核安全医学所 一种利用hmgb1的小肠放射性损伤标记方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079262A (en) * 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
JPH0539218A (ja) 1991-08-05 1993-02-19 Sanwa Kagaku Kenkyusho Co Ltd 放射線障害治療剤
JP3170364B2 (ja) 1992-11-05 2001-05-28 中外製薬株式会社 放射線障害防護剤
JPH07165602A (ja) 1993-12-16 1995-06-27 Kirin Brewery Co Ltd 放射線障害防護剤
AT407833B (de) 1995-06-01 2001-06-25 Nowicky Wassyl Dr Mittel zur behandlung von strahlenschäden
JP2003335674A (ja) 2002-03-12 2003-11-25 Mitsubishi Pharma Corp 放射線障害の予防剤および治療剤
JP2004043391A (ja) 2002-07-15 2004-02-12 Eisai Co Ltd 放射線障害軽減剤
WO2005053682A2 (en) 2003-11-26 2005-06-16 Arqule, Inc. Use of beta-lapachone for protecting against radiation injury
JPWO2006033412A1 (ja) 2004-09-24 2008-05-15 株式会社林原生物化学研究所 放射線障害軽減剤
JP2007302640A (ja) 2006-05-15 2007-11-22 Natl Inst Of Radiological Sciences 抗放射線被ばく障害剤
CA2722578C (en) 2008-05-14 2014-02-11 Sbi Alapromo Co., Ltd. Use of .delta.-amino levulinic acid to treat male infertility
JP5295652B2 (ja) * 2008-06-16 2013-09-18 Ｓｂｉファーマ株式会社 光障害の軽減剤
EP3192506A3 (en) 2008-10-27 2017-10-25 SBI Pharmaceuticals Co., Ltd. Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative or 5-aminolevulinic acid as active ingredient
JP5611548B2 (ja) 2009-07-08 2014-10-22 Ｓｂｉファーマ株式会社 ５−アミノレブリン酸若しくはその誘導体、又はそれらの塩を有効成分とするがんの予防・改善剤
JP5553306B2 (ja) 2010-03-30 2014-07-16 国立大学法人福井大学 放射線障害防護剤
CN104105482B (zh) * 2011-10-12 2017-10-24 思佰益药业股份有限公司 红细胞生成素产生促进剂

Also Published As

Publication number Publication date
EP2875812A4 (en) 2016-02-24
JP5920902B2 (ja) 2016-05-18
HK1206987A1 (en) 2016-01-22
CN104487066B (zh) 2020-06-09
JPWO2014017046A1 (ja) 2016-07-07
TW201412307A (zh) 2014-04-01
EP2875812A1 (en) 2015-05-27
CN104487066A (zh) 2015-04-01
WO2014017046A1 (ja) 2014-01-30
US20150190356A1 (en) 2015-07-09
TWI637743B (zh) 2018-10-11
EP2875812B1 (en) 2019-09-04
US9895331B2 (en) 2018-02-20

Similar Documents

Publication Publication Date Title
IL229323B (en) Device for radiation protection and methods thereof
HK1210031A1 (en) Therapeutic agent or prophylactic agent for dementia
HK1206666A1 (en) Phototherapy devices and methods
IL235536A0 (en) Material devices - on and methods for using them
EP2827935A4 (en) DEVICES AND METHODS FOR ENDOVASCULAR ACCESS AND THERAPY
EP2840951A4 (en) METHODS AND DEVICES FOR TISSUE RETRACTION
HK1216297A1 (zh) 腫瘤溶解綜合征的治療藥和預防藥
HK1214144A1 (zh) 干眼症預防/治療劑
EP2830617A4 (en) IPA AS A THERAPEUTIC AGENT, AS A PROTECTIVE AGENT AND AS A BIOMARKER FOR DISEASE RISKS
EP2884984A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
EP2537530A4 (en) RADIOTHERAPY AGENT
HK1206987A1 (en) Prophylactic and or therapeutic agent for radiation damage
IL234756A0 (en) A preparation for regulating the immune system and its uses
EP2931140A4 (en) Tissue repair equipment and methods
GB201214736D0 (en) Inflammation imaging and therapy
HK1209639A1 (en) Gpbp-1 inhibition and its therapeutic use gpbp-1
PL2882446T3 (pl) Terapia profilaktyczna i nutraceutyczna
EP2895186A4 (en) THERAPEUTIC COMPOSITIONS AND RELATED METHODS
EP2745838A4 (en) PROPHYLACTIC AGENT AND / OR THERAPEUTIC AGENT FOR SEPTICEMIA
HK1203159A1 (en) Prophylactic agent and or therapeutic agent for stress urinary incontinence
EP2817004A4 (en) BOUVARDIN DERIVATIVES AND THEIR THERAPEUTIC USES
EP2878344A4 (en) FIRE EXTINGUISHING AGENT AND FIRE EXTINGUISHING APPARATUS
EP2922165A4 (en) BATTERY PROTECTION APPARATUS AND BATTERY APPARATUS
GB201214234D0 (en) Prophylactic therapy